Structure-based pharmacophore modeling 2. Developing a novel framework for structure-based pharmacophore model generation and selection

被引:2
|
作者
Szwabowski, Gregory L. [1 ]
Daigle, Bernie J. [2 ,3 ]
Baker, Daniel L. [1 ]
Parrill, Abby L. [1 ]
机构
[1] Univ Memphis, Dept Chem, Memphis, TN 38152 USA
[2] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA
[3] Univ Memphis, Dept Comp Sci, Memphis, TN 38152 USA
关键词
Pharmacophore modeling; Ligand identification; Ligand discovery; Structure-based pharmacophore; GPCR; PROTEIN-COUPLED RECEPTORS; OPIOID RECEPTOR; CRYSTAL-STRUCTURE; DRUG DISCOVERY; ADENOSINE A(1); FINGERPRINTS; CHALLENGES; COMPLEX; TARGETS; LIGAND;
D O I
10.1016/j.jmgm.2023.108488
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Pharmacophore models are three-dimensional arrangements of molecular features required for biological activity that are used in ligand identification efforts for many biological targets, including G protein-coupled receptors (GPCR). Though GPCR are integral membrane proteins of considerable interest as targets for drug development, many of these receptors lack known ligands or experimentally determined structures necessary for ligand-or structure-based pharmacophore model generation, respectively. Thus, we here present a structure-based pharmacophore modeling approach that uses fragments placed with Multiple Copy Simultaneous Search (MCSS) to generate high-performing pharmacophore models in the context of experimentally determined, as well as modeled GPCR structures. Moreover, we have addressed the oft-neglected topic of pharmacophore model se-lection via development of a cluster-then-predict machine learning workflow. Herein score-based pharmaco-phore models were generated in experimentally determined and modeled structures of 13 class A GPCR and resulted in pharmacophore models exhibiting high enrichment factors when used to search a database containing 569 class A GPCR ligands. In addition, classification of pharmacophore models with the best performing cluster-then-predict logistic regression classifier resulted in positive predictive values (PPV) of 0.88 and 0.76 for selecting high enrichment pharmacophore models from among those generated in experimentally determined and modeled structures, respectively.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study
    Almasri, Ihab M.
    Taha, Mutasem O.
    Mohammad, Mohammad K.
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (11) : 1326 - 1337
  • [32] Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening
    Sun, Xu-Dong
    Zheng, Yi-Chao
    Ma, Chao-Ya
    Yang, Jing
    Gao, Qi-Bing
    Yan, Ying
    Wang, Zhi-Zheng
    Li, Wen
    Zhao, Wen
    Liu, Hong-Min
    Ding, Lina
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (16) : 4200 - 4214
  • [33] Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches
    Lee, Sehan
    Barron, Mace G.
    TOXICOLOGICAL SCIENCES, 2015, 148 (01) : 60 - 70
  • [34] Identification of potential inhibitors for LLM of Staphylococcus aureus: structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies
    Kumari, Reena
    Dalal, Vikram
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (20) : 9833 - 9847
  • [35] Development of Promising CDK5 Inhibitors Using Structure-Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Approach
    Ghosh, Amar
    Bhambri, Suruchi
    Solanki, Priyanka
    Jha, Prakash C.
    Manhas, Anu
    CHEMISTRYSELECT, 2024, 9 (43):
  • [36] A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation
    Thakur, Shikha
    Sinhari, Apurba
    Gaikwad, Anil Bhanudas
    Jadhav, Hemant R.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 756
  • [37] Structure-based studies of chemokine receptors
    Zhu, Lan
    Zhao, Qiang
    Wu, Beili
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2013, 23 (04) : 539 - 546
  • [38] Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process
    Opo, F. A. Dain Md
    Alsaiari, Ahad Amer
    Molla, Mohammad Habibur Rahman
    Sumon, Md Afsar Ahmed
    Yaghmour, Khaled A. A.
    Ahammad, Foysal
    Mohammad, Farhan
    Simal-Gandara, Jesus
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [39] Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders
    Pierri, Martina
    Gazzillo, Erica
    Chini, Maria Giovanna
    Ferraro, Maria Grazia
    Piccolo, Marialuisa
    Maione, Francesco
    Irace, Carlo
    Bifulco, Giuseppe
    Bruno, Ines
    Terracciano, Stefania
    Lauro, Gianluigi
    BIOORGANIC CHEMISTRY, 2022, 118
  • [40] Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists
    Katritch, Vsevolod
    Jaakola, Veli-Pekka
    Lane, J. Robert
    Lin, Judy
    IJzerman, Adriaan P.
    Yeager, Mark
    Kufareva, Irina
    Stevens, Raymond C.
    Abagyan, Ruben
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (04) : 1799 - 1809